Food and Drug Administration
-
FDA Moves to 'Marathon Strategy' for COVID-19 Vaccine
The Food and Drug Administration is taking on a “marathon strategy” in place of its originally adopted sprint mentality for the review, authorization and approval of a novel coronavirus vaccine, according to the agency’s Center for Biologics Evaluation and Research (CBER) Director Peter Marks.
7m read -
FDA Aims to Accelerate Data Modernization Through TMAP
The Food and Drug Administration is looking to modernize its internal technology infrastructure and the ways it uses data in regulatory processes through its Technology Modernization Action Plan (TMAP).
7m read -
Where Can Machine Learning Drive Efficiencies in Drug Development?
The Government Accountability Office identified to lawmakers potential use cases for machine learning in drug development to help drive efficiencies and cost savings.
7m read -
Partnerships in Focus for Cybersecurity Efforts at Health Agencies
As the federal government navigates an evolving cyber-threat landscape, health agency officials are increasing their attention toward expanding workforce recruitment, training and retention efforts to better safeguard personal health information.
7m read -
Data System Interoperability in Focus for Monitoring E-Cigarette Safety
Health agencies point to a need for modernized IT infrastructure and data-driven decisions.
7m read -
Machine Learning, Text Analytics Aid in Food Safety at FDA
A new automated data analytics program is crucial for the early detection of signals and predications for regulated chemicals that may pose highly hazardous health risks at the Food and Drug Administration.
10m read -
A Look at Policy and Data with FDA CTP's Mitch Zeller
The center uses significant data processes and analytics in the effort to curb tobacco-related disease and death.
35m listen
